Simvastatin and supplementation with ω-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease

Nutrition Research

Volumn 26, Issue 12, 2006, Pages 637-643

  Carrero, Juan J ^a   López Huertas, Eduardo ^b   Salmerón, Luis M ^c   Ramos, Victoria E ^c   Baró, Luis ^b   Ros, Eduardo ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b Puleva Biotech SA   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

B vitamins; Fish oil; Folic acid; Human; Intermittent claudication; Peripheral vascular disease; Simvastatin

Indexed keywords

ALPHA TOCOPHEROL; CALCIUM; CARBOHYDRATE; CHOLESTEROL; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FISH OIL; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; OMEGA 3 FATTY ACID; PENTOXIFYLLINE; POLYUNSATURATED FATTY ACID; PROTEIN; PYRIDOXINE; RETINOL; SIMVASTATIN; TRIFLUSAL; VITAMIN D;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEART PROTECTION; HUMAN; INTERMITTENT CLAUDICATION; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MALE; MILK; NUTRIENT MANAGEMENT; NUTRITIONAL COUNSELING; NUTRITIONAL HEALTH; NUTRITIONAL SUPPORT; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SYMPTOM; THERAPY EFFECT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 33845295799     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.09.024     Document Type: Article

References (38)

1. Hirsch A.T., Hiatt W.R., and PARTNERS Steering Committee. PAD awareness, risk, and treatment: new resources for survival-the USA PARTNERS program. Vasc Med 6 (2001) 9-12
2. Donnelly R., and Yeung J.M.C. Management of intermittent claudication: the importance of secondary prevention. Eur J Vasc Endovasc Surg 23 (2002) 100-107
3. Leng G.C., and Fowkes F.G.R. The epidemiology of peripheral arterial disease. Vasc Med Rev 4 (1993) 5-18
4. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
5. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
6. Mukherjee D., Lingam P., Chetcuti S., Grossman P.M., Moscucci M., Luciano A.E., et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 106 (2002) 1909-1912
7. Cassar K., Coull R., Bachoo P., Macaulay E., and Brittenden J. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg 26 (2003) 262-266
8. Norman P.E., Eikelboom J.W., and Hankey G.J. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med J Aust 181 (2004) 150-154
9. McDermott M.M., Guralnik J.M., Greenland P., Pearce W.H., Criqui M.H., Liu K., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107 (2003) 757-761
10. Sommerfield T., and Hiatt W.R. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev 3 (2004) CD003833
11. Ramirez-Tortosa M.C., Urbano G., Lopez-Jurado M., Nestares T., Gomez M.C., Mir A., et al. Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr 129 (1999) 2177-2183
12. Aguilera C.M., Mesa M.D., Ramirez-Tortosa M.C., Nestares M.T., Ros E., and Gil A. Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr 23 (2004) 673-681
13. Kleijnen J., and Mackerras D. Vitamin E for intermittent claudication. Cochrane Database Syst Rev 2 (2000) CD000987
14. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97 (1998) 437-443
15. Wilmink A.B., Welch A.A., Quick C.R., Burns P.J., Hubbard C.S., Bradbury A.W., et al. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg 39 (2004) 513-516
16. Hooper L., Griffiths E., Abrahams B., Alexander W., Atkins S., Atkinson G., et al. Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update, June 2003). J Hum Nutr Diet 17 (2004) 337-349
17. Baro L., Fonolla J., Pena J.L., Martinez-Ferez A., Lucena A., Jimenez J., et al. n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 22 (2003) 175-182
18. Carrero J.J., Baro L., Fonolla J., Gonzalez-Santiago M., Martinez-Ferez A., Castillo R., et al. Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition 20 (2004) 521-527
19. Mataix J., Mañas M., Llopis J., and Martinez-Victoria E. Tabla de composición de alimentos españoles (1998), Universidad de Granada, Granada (Spain)
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Lepage G., and Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27 (1986) 114-120
22. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
23. Tabet S., Berg A.O., and for the US Preventive Services task Force. Screening for peripheral arterial disease. Guide to clinical preventive services: report of the US Preventive Services Task Force (1996), Williams and Wilkins, Baltimore, MD 63-66
24. Rader J.I. Folic acid fortification, folate status and plasma homocysteine. J Nutr 132 (2002) 2466-2470
25. Lawson L.D., and Hughes B.G. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun 156 (1988) 960-963
26. Visioli F., Rise P., Plasmati E., Pazzucconi F., Sirtori C.R., and Galli C. Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerols and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 41 (2000) 571-576
27. Third Report of the National Cholesterol Education Programme Expert Panel on "detection, evaluation and treatment of high blood cholesterol in adults (ATP III)". 2002 National Institutes of Health (NIH), publication number 02-5215.
28. Mason J.C. Statins and their role in vascular protection. Clin Sci (Lond) 105 (2003) 251-266
29. Mohler III E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 12 (2003) 1481-1486
30. Mondillo S., Ballo P., Barbati R., Guerrini F., Ammaturo T., Agricola E., et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 5 (2003) 359-364
31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
32. Aronow W.S., Nayak D., Woodworth S., and Ahn C. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol 92 (2003) 711-712
33. Ernst E. Effects of n-3 fatty acids on blood rheology. J Intern Med Suppl 225 (1989) 129-132
34. Ho M., Maple C., Bancroft A., McLaren M., and Belch J.J. The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology. Prostaglandins Leukot Essent Fatty Acids 61 (1999) 13-17
35. Vicaut E. Opposite effects of red blood cell aggregation on resistance to blood flow. J Cardiovasc Surg 36 (1995) 361-368
36. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
37. De Vriese A.S., Blom H.J., Heil S.G., Mortier S., Kluijtmans L.A., Van de Voorde J., et al. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 109 (2004) 2331-2336
38. Spark J.I., Robinson J.M., Gallavin L., Gough M.J., Homer-Vanniasinkam S., Kester R.C., et al. Patients with chronic critical limb ischemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg 24 (2002) 535-539